Saddam Al Demour
Amman, 11942, Jordan
NCT Number: NCT04363970
Transurethral resection of prostate is the gold standard operation for bladder outflow obstruction due to benign prostatic enlargement. However, catheter removal day is variable. The objective of this study is to compare early and delayed catheter removal groups in terms of, urinary retention after catheter removal, length of hospital stay, weight of resected prostate, duration of resection, peri-operative blood transfusion, and postoperative complications.
Looking for future studies?
Notify Me45 year–90 year
Male
Observational
Amman, 11942, Jordan
This randomized controlled trial will carried out in Urology clinic at Jordan university hospital. Patients with benign prostate hyperplasia will be selected by simple random sampling technique after taking informed consent and will divided into two groups: Group A- early catheter removal group( catheter removed after 24 hours) and Group B-delayed catheter removal group ( catheter removed after 48 hours). in this study we will exclude patients with large post-void urine volume, simultaneous internal urethrotomy and transurethral resection of prostate, co-morbidity( diabetes mellitus, CVA) spinal cord injury, urethral stricture, prostate cancer proved by biopsy and intra-operative complications. Patients will discharged after removal of catheter if they voided successfully.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
in group A, we will remove the catheter after 24 h. In group B, we will remove the catheter after 48 h.
Time frame: after 3 months.
inability to void
Time frame: after 3 months.
urinary symptoms after the procedure.
University of Jordan
Other
Early Versus Delayed Removal of the Urethral Catheter After Trans Urethral, Randomized Clinical Trial.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00700505
Benign Prostatic Hyperplasia (BPH), Female Urogenital Diseases
Houston, Texas, United States
View Trial DetailsNCT00029822
Benign Prostatic Hypertrophy, Female Urogenital Diseases
Huntsville, Alabama, United States
View Trial DetailsNCT00680680
Benign Prostatic Hyperplasia, Female Urogenital Diseases
View Trial DetailsNCT07699718
Benign Prostatic Hyperplasia, Benign Prostatic Obstruction
Van, Edremit, Turkey (Türkiye)
View Trial Details